Unexpected Repigmentation of Vitiligo Universalis Following Hemodialysis Initiation: A Rare Case Report and Literature Overview.

IF 1.9 4区医学 Q3 DERMATOLOGY

Clinical, Cosmetic and Investigational Dermatology Pub Date : 2024-11-08 eCollection Date: 2024-01-01 DOI:10.2147/CCID.S482396

Abdulaziz A Alnoshan, Fahad Hamoud Alrashdi, Rawan Abdulaziz AlDahash, Khalid Nabil Nagshabandi, Salman Alotaibi

引用次数: 0

Abstract

Vitiligo is a chronic skin depigmentation disorder affecting 0.2-1.8% of the global population, with a significant prevalence in Saudi Arabia. Although not life-threatening, it severely impacts the quality of life and psychological well-being of patients. We report a rare instance of hemodialysis-induced skin repigmentation involving a 25-year-old woman with vitiligo universalis.

查看原文本刊更多论文

开始血液透析后泛发型白癜风的意外再色素沉着：罕见病例报告与文献综述。

白癜风是一种慢性皮肤色素脱失症，占全球人口的 0.2%-1.8%，在沙特阿拉伯的发病率很高。虽然不会危及生命，但它严重影响患者的生活质量和心理健康。我们报告了一例罕见的血液透析诱发皮肤再色素沉着的病例，患者是一名患有泛发型白癜风的 25 岁女性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical, Cosmetic and Investigational Dermatology Medicine-Dermatology

CiteScore

2.80

自引率

4.30%

发文量

353

审稿时长

16 weeks

期刊介绍： Clinical, Cosmetic and Investigational Dermatology is an international, peer-reviewed, open access journal that focuses on the latest clinical and experimental research in all aspects of skin disease and cosmetic interventions. Normal and pathological processes in skin development and aging, their modification and treatment, as well as basic research into histology of dermal and dermal structures that provide clinical insights and potential treatment options are key topics for the journal. Patient satisfaction, preference, quality of life, compliance, persistence and their role in developing new management options to optimize outcomes for target conditions constitute major areas of interest. The journal is characterized by the rapid reporting of clinical studies, reviews and original research in skin research and skin care. All areas of dermatology will be covered; contributions will be welcomed from all clinicians and basic science researchers globally.